BioSpace - Print News Article

AstraZeneca PLC (AZN) Not Done With Cost Cuts 11/12/2010 7:48:24 AM NEW YORK (Reuters) - AstraZeneca Plc (AZN.L), facing patent expirations on its top-selling medicines, sees room for more cost cuts in marketing, sales and other areas to shore up profits, its chief executive said on Wednesday.

AstraZeneca PLC (AZN) Not Done With Cost Cuts
11/12/2010 7:48:24 AM

NEW YORK (Reuters) - AstraZeneca Plc (AZN.L), facing patent expirations on its top-selling medicines, sees room for more cost cuts in marketing, sales and other areas to shore up profits, its chief executive said on Wednesday.